Press Releases Willow Biosciences Inc.

Equities

WLLW

CA97111B4047

End-of-day quote Toronto S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
0.11 ^CAD	+10.00%		+4.76%	+10.00%

06-26	Willow Biosciences Provides Corporate Update and Signs New Partnered Program	MT
06-26	Willow Biosciences Brief: Announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM	06-26	AQ
Willow Bioscience Announces 3 Million dollar Fundraising to Support Partnership with Laurus Labs	06-07	AQ
WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION	06-03	AQ
WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS	05-30	AQ
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	03-28	AQ
WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	01-31	AQ
WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	01-16	AQ
Willow Bioscience plans to advance development program with Nasdaq-listed company	12-11	AQ
WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	11-14	AQ
WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING	11/10/23	AQ
Willow Bioscience teams again with Suanfarma on large volume anti-infective API	05/10/23	AQ
WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION	03/10/23	AQ
Willow Bioscience eyes another use for BioOxi platform with R&D of ursodeoxycholic acid	12/09/23	AQ
WILLOW BIOSCIENCES ANNOUNCES COMPANY INSIDER LED CONVERTIBLE DEBENTURE FINANCING	12/09/23	AQ
WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCA	06/09/23	AQ
Willow Bioscience files patent to help reduce costs of corticosteroids	04/09/23	AQ
WILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COST	31/08/23	AQ
Willow Bioscience shifts focus to opportunity with BioOxi bio-oxidation platform	29/08/23	AQ
WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS	08/08/23	AQ
WILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON AUGUST 9	02/08/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Willow Biosciences Inc.

Equities

WLLW

CA97111B4047

Press Releases

Filters